3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Breast
8
Plasma cell
2
Other hematologic neoplasm
2
Lymphoid
2
Gastrointestinal
2
CNS
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Interventions
Cyclophosphamide
7
fludarabine phosphate
5
Whole-Body Irradiation
5
Mycophenolic Acid
4
Busulfan
4
fludarabine
3
Tacrolimus
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Melphalan
3
Cyclosporine
3
Biopsy
3
venetoclax
2
apixaban
2
Tretinoin
2
Specimen Handling
2
Methotrexate
2
Lenalidomide
2
Etoposide
2
CT-P10
2
Azacitidine
2
Antilymphocyte Serum
2
thymoglobulin
1
merphos
1
ivosidenib
1
ibrutinib
1
edoxaban
1
decitabine and cedazuridine drug combination
1
acalabrutinib
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ado-Trastuzumab Emtansine
×
Classical hematology
×
30 days
×
Clear all
No trials found.